Publication | Closed Access

Berbamine: A novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity

Hematological MalignancyPotent Anti-leukemia ActivityNovel InhibitorMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderBcr/abl Fusion GeneAnti-cancer AgentPharmacologyCell BiologyCancer ResearchTumor BiologyMyeloid Neoplasia